Ponatinib hydrochloride is the hydrochloride salt of ponatinib, a potent pan-inhibitor of tyrosine kinases that is active against all single resistance ABL kinase mutations, including the T315I mutation. It is an antineoplastic agent used in pharmaceutical manufacturing and research for chronic myeloid leukemia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1114544-31-8
Ponatinib
pharmaceutical raw material
Wz-4002
pharmaceutical raw material
Repotrectinib
pharmaceutical raw material
Selitrectinib
pharmaceutical raw material
IDRX-42
pharmaceutical raw material
Amlodipine besylate
pharmaceutical raw material
Metformin hydrochloride
pharmaceutical raw material
5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
pharmaceutical raw material
3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide;hydrochloride
BWTNNZPNKQIADY-UHFFFAOYSA-N
CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5.Cl